neuroendocrine carcinoma


Also found in: Dictionary, Thesaurus, Encyclopedia.

neuroendocrine carcinoma

tumor originating in neuroendocrine cells; most common in the lung, but may occur in any organ.

neuroendocrine carcinoma

Any of a diverse group of malignancies, such as carcinoid, islet cell tumors, neuroblastoma, and small-cell carcinomas of the lung. All have dense core granules and produce polypeptides that can be identified by immunochemical methods.
See also: carcinoma
References in periodicals archive ?
A new virus, Merkel cell polyomavirus (MCPyV), recently was discovered in humans with Merkel cell carcinoma (MCC), a relatively rare, aggressive primary cutaneous neuroendocrine carcinoma.
The grade is inherent in some lung cancer diagnoses; for example, small cell carcinoma, large cell neuroendocrine carcinoma, and sarcomatoid carcinomas are poorly differentiated.
The exact relation between neuroendocrine carcinoma and UEC needs further elaboration.
Annualized data on the seven key Neuroendocrine carcinoma markets revenue data (the US, France, Germany, Italy, Spain, the UK and Japan) from 2006 to 2011, forecast for eight years to 2019.
Annualized data on the seven key neuroendocrine carcinoma markets (the US, France, Germany, Italy, Spain, the UK and Japan) revenue data from 2006 to 2011, forecast for eight years to 2019.
AMEX: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders, announced today promising interim data from the company's ongoing open-label Phase II clinical trial of Atiprimod to treat low to intermediate grade neuroendocrine carcinoma (advanced carcinoid cancer).
Neuroendocrine carcinoma is further subdivided into SmCC and large cell neuroendocrine carcinoma, the latter of which is vanishingly rare in the urinary bladder.
We describe what we believe is the first reported case of an atypical carcinoid tumor, or any other type of neuroendocrine carcinoma, of the uvula.
Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders and diseases, announced today that complete enrollment of its Phase II clinical trial of Atiprimod to treat low to intermediate grade neuroendocrine carcinoma (advanced carcinoid cancer) was accomplished ahead of schedule.
Unusual malignancies arising from BO include adenosquamous carcinoma, squamous cell carcinoma, sarcomatoid carcinoma, neuroendocrine carcinoma, choriocarcinoma and yolk sac tumours.
Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature.